Dulaglutide mantiene una base di utenti stabile tra le compagnie assicurative private brasiliane che ne prediligono il design autoiniettore, mentre il regime di iniezione giornaliera di liraglutide sta perdendo terreno rispetto ai rivali a pi lunga durata d'azione
Semaglutide Semaglutide is a GLP-1 receptor agonist that is dosed once a week subcutaneously based on its extended half-life
Common side effects are typically mild and manageable, while serious adverse events remain rare
Self-pay consultation options are available for patients who do not have insurance coverage or who prefer to pay out of pocket
Parker VER, Robertson D, Wang T et al (2020) Efficacy, safety, and mechanistic insights of cotadutide, a dual receptor glucagon-like peptide-1 and glucagon agonist
Policymakers must carefully weigh immediate costs against the future benefits, ensuring that these life-changing medications are available to all who need them